Angiotensin-converting enzyme (ACE) inhibitor; hydrolyzed in vivo to the active diacid metabolite. Prepn: M. R. Attwood et al., DE 3317290; eidem, US 4512924 (1983, 1985 both to Hoffmann-La Roche); eidem, J. Chem. Soc. Perkin Trans. 1 1986, 1011. HPLC determn in urine and pharmaceutical formulations: J. A. Prieto et al., J. Chromatogr. B 714, 285 (1998). Pharmacology: I. L. Natoff et al., J. Cardiovasc. Pharmacol. 7, 569 (1985). Review of clinical pharmacology: C. H. Kleinbloesem et al., Am. J. Med. 87, Suppl. 6B, 45S-49S (1989). Review of clinical experience in hypertension: T. Szucs, Drugs 41, Suppl. 1, 18-24 (1991); in chronic heart failure: L. D"ossegger et al., J. Cardiovasc. Pharmacol. 24, Suppl. 3, S38-S41 (1994); in combination with hydrochlorothiazide: R. C. Pordy, Cardiology 86, 41-48 (1995).
Antihypertensive.
ACE-Inhibitor; Antihypertensive; N-Carboxyalkyl (peptide/lactam) Derivatives